Chimera Investment Corporation (CIM) Earnings Call Transcript & Summary
August 5, 2020
Earnings Call Speaker Segments
Emily Mohr
executiveThanks, Nicole, and thanks to all of you for joining us on Chimera's conference call covering our second quarter results. Before we get started, I want to go over the safe harbor statement. On this call, we'll be providing forward-looking statements, meaning predictions, projections, or other remarks concerning events yet to come. Such statements rest on present expectations and assumptions that carry risks and uncertainties, and those are described in the Risk Factors section of our latest annual and quarterly SEC filings. What actually happens and what we actually report could end up differing materially from those forward-looking statements. We'd urge you to look at the forward-looking statement disclaimer included in our earnings release, along with our quarterly and annual filings. On today's call, we might also cover non-GAAP financial measures. For a reconciliation to the most comparable GAAP measures, please see our SEC filings and earnings supplement. Also, what's said on this conference call could include time-sensitive information that holds true only as of the date of this earnings call. We don't assume, and we specifically disclaim, any duty to update or revise this information. Now I'll hand the conference over to Matthew Lambiase, our President and Chief Executive Officer.
Matt Lambiase
executiveHello, everyone, and thanks for joining us for Chimera Investment Corp.'s second quarter earnings call. Here with me today are Mohit Marria, who serves as our Chief Investment Officer; Rob Colligan, our Chief Financial Officer; Choudhary Yarlagadda, our Chief Operating Officer; and Vic Falvo, who leads our Capital Markets. I'll offer a few quick remarks, after which Mohit will walk through what's changed in the portfolio, and then Rob will go over our financial results. Once that's done, we'll take your questions. In my view, the first 6 months of 2020 will be remembered in the financial history books as among the most volatile stretches seen in modern times. Within only a few months, the U.S. economy shifted from excellent to dismal, and the financial markets, fixed income in particular, saw unprecedented volatility along with unprecedented government intervention; in our sector, a great many levered investors were taken by surprise when asset prices dropped so quickly, and they ended up having to sell at the market's bottom. Luckily, Chimera managed to get through this challenging stretch by completing transactions that let us hold onto our unique, high-yielding mortgage credit portfolio. It's key to recognize that recreating our portfolio would be extremely hard, perhaps even impossible, given today's low interest rate environment, and keeping it gives Chimera the capacity to pay a meaningful dividend — something we wouldn't have had if those assets had been sold; during the quarter, we took a number of steps that helped us boost our liquidity: we issued a $374 million 3-year convertible bond; we put in place a $400 million 3-year revolving loan facility arranged by Ares Capital; and we completed 3 new mortgage securitizations totaling over $1 billion, which sharply cut our loan warehouse exposure and helped reopen the mortgage securitization market, a primary source of Chimera's long-term financing. On top of that, during the period, we negotiated longer-term, non-market — we negotiated longer-term and non-mark-to-market repo finance facilities for our mortgage loans and credit-related assets. At this point, roughly 75% of our credit borrowings sit on longer-term facilities, and more than 50% of them carry no mark-to-market or limited mark-to-market arrangements. Although these steps have raised financing costs in the short term, we see the long-term benefits as significant; we've made our balance sheet stronger, which lets us better withstand further market volatility, keep generating attractive spread income and make new investments whenever appealing asset opportunities arise. That's an enviable position, considering the uncertain economic conditions and the low return environment we're operating in right now. The Federal Reserve has said it expects to hold the Fed funds rate at 0 for the next 2 years and to keep purchasing large quantities of assets in support of the financial markets and the U.S. economy. We are currently seeing the impact of those actions. The yield on the 10-year treasury sits at about 55 basis points right now, and for the first time ever, the rate on a new 30-year mortgage has fallen under 3%. Market expectations today suggest this environment of low rates will persist for a number of years ahead, and that returns across all financial assets will likewise be low going forward. Although the Federal Reserve's asset purchases haven't been aimed directly at residential mortgage credit, those purchases have begun to firm up the markets, and senior mortgage bonds have seen meaningful price appreciation. Our expectation is that, with time, deeper credit subordinate residential bonds might experience comparable moves. As the Fed keeps buying assets and market returns grow ever scarcer, Chimera's portfolio of higher-yielding legacy assets ought to become more and more valuable. Because of the market's size and the sluggish recovery in pricing, residential mortgage credit presented some of the finest opportunities available in fixed income. Loan securitization's economics remain appealing, since the credit curve is still steep. With senior front-end bonds well bid, there's a chance to securitize loans and hold onto higher-yielding, back-end subordinate investments; such subordinated bonds carry high relative yield along with the potential for substantial appreciation if markets normalize; during the period we completed 3 securitizations and kept the subordinate tranches from those deals. Going forward, we think there will be plenty of loans available for purchase from the GSEs and banks, and that supply will generate opportunities for us to make fresh investments in our portfolio. In light of today's low-yield and low-return conditions, we believe that being able to build investments via securitization will let us keep delivering attractive results in this tough market. Although navigating this stretch has been extremely hard, we believe Chimera is well positioned going forward; we've substantially cut our exposure to mark-to-market risk on our repo financings, which ought to help us get through future bouts of volatility; we've managed to keep our legacy portfolio of assets, which will let us keep paying meaningful dividends to our investors during what could be a prolonged stretch of low interest rates. If pricing goes back to historical levels, the retained portfolio could also deliver book value appreciation. And last, we believe appealing opportunities exist right now in the residential loan market, and we have a team, plus a track record, of being able to employ securitization to successfully build high-yielding investments for our portfolio; and with that, I'll hand the call over to Mohit.
Mohit Marria
executiveThanks, Matt. Because of the monetary and fiscal backing the government supplied on a scale never seen before, the equity and fixed income markets both improved substantially during the second quarter. Some segments of equities are flat to higher on a year-to-date basis, and treasury rates held steady in Q2. Since rates stayed steady and the Fed keeps signaling that rates will remain lower for the foreseeable future, volatility has come down. The crowding-out impact from the Fed's intervention in the markets has benefited every highly rated fixed income security. The Federal Reserve concentrated largely on agency securities and bought no residential mortgage credit; given how few legacy credit assets were available following a sluggish start in April, new issue securitization volumes were strong in the second quarter. Senior tranches of securitized residential product improved at a steady pace, with the best results coming in the back half of the second quarter. During the quarter, our attention was on the liability side of our balance sheet, and we entered into 3 non-mark-to-market facilities to finance $2 billion of our non-agency portfolio. We also have limited mark-to-market on $611 million of non-agency securities. Thanks to these transactions, roughly 54% of our non-agency borrowings carry no full mark-to-market risk. At quarter end, the weighted average term to maturity had risen to 698 days, up from 223 days in the first quarter. To lower the risk on our warehouse lines, we finished 3 securitizations, totaling approximately $1.1 billion in seasoned, reperforming mortgage loans. Shifting loans from warehouse into securitization matters a great deal to our portfolio strategy, since it cuts mark-to-market risk and strengthens the company's risk metrics. Following this quarter's securitization, our residential mortgage loan warehouse sits at $263 million and is financed for 1 year with no mark-to-market risk. CIM 2020-R3, issued in May, had $438 million underlying loans, a weighted average coupon of 5.28%, and a weighted average loan age of 150 months. In the R3 securitization, the average loan size was $127,000, and the average FICO was 651, with an average LTV of 80%. We sold $329 million senior securities at a 4.2% cost of debt. Chimera kept a May 2022 calendar call option for the R3 securitization. CIM 2020-R4 had $276 million underlying loans, a weighted average coupon of 4.78%, and a weighted average loan age of 168 months. The average loan size in the R4 was $127,000. The average FICO was 598, with an average LTV of 75%. We sold $207 million senior securities at a 3.2% cost of debt. Chimera kept a June 2022 calendar call option on the R4 securitization; in early July, Chimera finished the year's second rate of securitization; we issued CIM 2020-R5 with $338 million underlying loans and an average coupon of 4.98%. The R5 securitization had a weighted average loan age of 149 months and an average loan size of $152,000. The loans carried a weighted average FICO of 678, with an average LTV of 70%. We completed sales of $257 million in investment-grade securities at a 2.05% cost of debt, which came in more than 200 basis points tighter than the deal we did in early May. Then, in late July, we issued $362 million of CIM 2020-J1, marking our first jumbo securitization for this year. On the whole, we feel good about where the investment portfolio stands today and what it can achieve over the long term. Navigating this challenging stretch was possible because we kept executing transactions, and that lets us hold onto our high-yielding, unique mortgage credit portfolio. Solid credit performance, the strength of institutional buying, and new issue credit spreads tightening all played positive roles in Chimera's long-term securitization strategy. We currently have 13 existing CIM securitizations, adding up to $7.5 billion, that are available for call and refinancing across the next 12 months. That gives us one more path toward portfolio performance and works alongside possible new investment opportunities; we keep watching our outstanding securitizations closely to find the best timing and the chance to carry out our call optimization strategy and maximize long-term portfolio performance for our shareholders. Our Agency CMBS keep delivering attractive spread income and liquidity for the portfolio, and they offer superior call protection compared with residential agency pass-throughs in this low rate environment. Finally, the reduction in mark-to-market that we achieved this quarter leaves us with plenty of dry powder for making new credit investments. I'll now hand the call over to Rob, who will review the financial results for the quarter.
Rob Colligan
executiveThank you, Mohit. I'll now walk through the key financial results for Chimera during the second quarter. At the close of Q2, our GAAP book value stood at $10.63 per share. The GAAP net loss we recorded for Q2 came to $73 million, which works out to $0.37 per share. When looking at core results, net income for the second quarter reached $76 million, or $0.32 per share. Economic net interest income during Q2 totaled $121 million. In Q2, the yield we earned on interest-earning assets came in at 5.7%, while our average cost of funds was 3.3%, producing a net interest spread of 2.4%. Total leverage during the second quarter was 4.3:1, and recourse leverage finished the quarter at 1.8:1. Q2 expenses, once servicing fees and transaction expenses are excluded, amounted to $17 million, which is lower than the prior quarter, mainly because compensation costs declined. Right now we hold roughly $850 million in cash along with unencumbered assets; that figure comes after paying our preferred and common dividends in full. We keep watching liquidity carefully and are seeking appealing financing opportunities to back our portfolio. That wraps up our prepared comments, and at this point we'll take questions on the call.
Doug Harter
analystRegarding that final item about the $850 million in cash, how do you think about what constitutes the appropriate amount to keep on hand, considering the uncertainties, yet also taking into account the better financing arrangements you now have? And what's the right way for us to consider your capacity to put some of those funds to work?
Rob Colligan
executiveHi, Doug, I appreciate the question. If you go back to what was said during the prior quarter's call, the figure stood at $650 million, which means we've added roughly $200 million in cash and liquidity, or unencumbered assets. As you clearly picked up from those remarks, a great deal of our attention this quarter went toward securitization and securing long-term financing; as a result, the liability portion of our balance sheet looks vastly different from where it was three months ago; and that clearly positions us to bid aggressively. I'm confident Mo or Matt could address what lies ahead and the pipeline.
Mohit Marria
executiveHi Doug, Mohit here. I just want to build on what Rob said. Right, during Q2 our attention went toward strengthening the balance sheet's liability side, and that work is complete. In our view, the cash plus unencumbered assets we currently hold provide a certain amount of dry powder for putting capital to work in appealing opportunities. Early in Q2, there were, in a sense, liquidations — forced ones — which handed some investors easy pickings. Within that quarter, loan activity on the season reperforming side was fairly minimal. More of it centered on the non-QM side, yet we believe there will be plenty of chances to buy assets and put the capital and liquidity sitting on our balance sheet to use.
Doug Harter
analystGreat. And then, Rob, could you discuss what the added expense might be for the enhanced structures related to the financing you all arranged during Q2?
Rob Colligan
executiveYeah; regarding better financing, that's a fascinating question. Clearly, before COVID, repo expenses were much cheaper, and haircuts were reduced as well. So how I see it, I suppose, is that our costs have risen, likely similar to what most others in our sector have experienced. I believe repo availability, particularly for non-agency, is improved compared to a few months back, yet it remains not very active or liquid. However, thinking further ahead, as hopefully COVID cases decline and solutions are implemented, individuals return to their jobs, everything will return to normal, and there's an opportunity for us, eventually, to lower our liability expenses and boost our profits. Yet in the near term, clearly, much like many others in our sector, our financing expense has increased somewhat.
Mohit Marria
executiveOkay. Doug, I want to expand a bit on what Rob said. On the recourse repo financing side, obviously, pricing has risen everywhere. That's an immediate response to the liquidity that had to be supplied when the crisis hit. On the nonrecourse side, though, we completed 3 securitizations during the quarter, with the first in May, and like we noted in the opening statement, the debt cost we issued, the financing there, was 4.2%. Then when we closed that deal at July's end, the financing cost stood at 2.05%. So the securitization market is recovering. Demand is strong for the senior portions of the capital structure, and that financing cost has dropped significantly between the quarter's start and its finish, and we believe it can tighten further still, since legacy assets are in short supply.
Steve Laws
analystThis is somewhat of a follow-up to what Doug asked during your prepared remarks. When I consider leverage recourse, I think about 1.8, and then the total is a bit higher. You mentioned new investments, but could you discuss where you expect the leverage figures to go as we consider portfolio growth perhaps across the coming 18 months? And you brought up the liabilities; and will these be funded initially with recourse debt and then transition to non-mark-to-market via future securitizations? Or do you currently have sufficient capacity on non-mark-to-market facilities to fund these new investments?
Mohit Marria
executiveHey, Stephen, it's Mohit once more. I'll kick it off. Rob and Matt can also weigh in on it. At this point, our non-mark-to-market facilities have no remaining capacity—they're completely drawn—so adding exposure there isn't possible without establishing a new facility. As for where leverage stands and our plans going forward: we started this year at 3.2 turns of recourse leverage, and we've since reduced it to 1.8 turns. Will we get back to where we were before COVID? Not anytime soon, in our view. Our approach will be disciplined when putting capital to work, and we'll avoid resorting to recourse leverage unless the terms are favorable and the tender is something that makes sense for us. As Matt mentioned during his opening remarks, I believe that if we build relationships we keep from the capital we deploy, those will generate returns in the high single digits on a cash basis, with additional potential tied to performance. My sense is that attention remains fixed on forbearance and deferment activity, along with what further stimulus measures the government may introduce. In my view, there's room for credit results to improve from here. What occurred during Q1 and the initial portion of Q2 amounted purely to a liquidity issue. When you examine the metrics behind our credit results, they've been quite strong, and there hasn't been much variation in our portfolio compared with the trends seen during January, February, and March of this year.
Matt Lambiase
executiveYeah, and to add to what was just said — as we move further and further past what happened back at the close of March and the start of April, my sense is that eventually the financing markets are going to reopen at some point down the road, and it's possible you'd see the company's overall leverage rise. That said, we would need to feel we're clearly past the danger before taking that step. And looking ahead, I think there's some upside sitting on our balance sheet.
Steve Laws
analystOkay, and Mohit, I want to piggyback on that. You brought up possible upside, which happens to be what I was going to ask about next. Thinking about it — during your prepared comments, you mentioned the option of keeping those assets rather than selling them. That decision clearly benefited earnings because of the cash flow produced. Yet we still hold a substantial amount of unrealized marks on assets from the first six months of the year. What's your take on that? My sense is that's a fairly large figure. So of those unrealized marks, how much would you consider potentially recoverable? I'm not sure how you'd estimate that against the core visibility going forward. But regarding what you're bringing up, given certain marks tied to liquidity and similar factors, it appears a portion of these assets may be priced below what they'll be worth 6 or 12 months down the line. So what's your thinking on how much could come back, how big that rebound might be, and when the unrealized portions from the first half might reverse?
Mohit Marria
executiveAbsolutely. That's a worthwhile area to zero in on, since — as I was just saying — the situation in March came purely from liquidity pressures rather than anything rooted in credit, and everyone's going to hold off until they can observe how the assets performed across April, May and June. At the time, there was concern that the pandemic would lead to significant joblessness, and that's what happened. However, thanks to the stimulus payments and how our portfolio was positioned, the impact on our portfolio's cash flows wasn't all that dramatic in a material way. So in our view, the portfolio is undervalued; and when you examine how the portfolio has performed—looking at both delinquency and loss metrics from Q4 through the close of Q2—the delinquency figures have stayed fairly level. As we've mentioned many times, the 60-plus day delinquency rate for the portfolio sits squarely in the mid-8% to mid-9% range. If we set aside the pandemic's effects, our expectation is that prices could recover to where they stood in Q4. The unrealized P&L we'd recoup from that is just north of $550 million, which would move book value by roughly $2.50. That figure reflects our view of what these assets are truly worth. Consider the rate movement between Q4 and Q2 — a 140 basis point shift spanning the 2-year to the 10-year point — and that rally in rates ought to influence pricing as well. Our non-agency portfolio carries an average duration of about 5 years, which points to a price change of 7 points. Now we're not going to get basis point for basis point move in price appreciation. So if you haircut that 7-point move and take only 25% of that, that's an additional $1.50 of book value appreciation. Thus, in our view, assuming market conditions settle down and results get factored in — since results genuinely were considered — our book value ought to land somewhere in the range of $13 to $14, compared with the $10.63 where we currently stand.
Rob Colligan
executiveRight, Stephen, I’ll just mention one additional point there. Clearly, there’s opportunity to do better, but we do have secured debt, along with liabilities on our balance sheet that we also mark-to-market. And those have bounced back at a much quicker pace, the more senior securities; they’ve rebounded considerably faster. Most recoveries tend to be uneven or lopsided. So for us, that’s a near-term decrease, since that’s a liability on our books; and those have regained value far more rapidly than the loans or securities held on our books. So again, eventually, everything should converge to what Mohit was referring to, but I just wanted to highlight that from the liability perspective and some near-term impacts to book value.
Eric Hagen
analystOut of that $5.9 billion total repo, how much of the balance goes toward funding non-agency assets? And what kind of collateral sits on that repo line?
Mohit Marria
executiveEric, Mohit here. On the non-agency side, repo borrowings come to $3.6 billion. Securities account for $3 billion of that, while warehouse loans we hold make up $600 million of it. Within that $3 billion, $1.3 billion of the borrowing is done on a non-mark-to-market basis on the security side. Those are our legacy assets — the re-REMICs we created back in 2008, 2009, certain middle mezz positions we've created off of our securitizations, plus our risk retention pieces. So what's being financed covers a gamut of what we own.
Eric Hagen
analystUnderstood. Now regarding that $600 million in loans, what does the collateral profile look like?
Mohit Marria
executiveThose loans — that $600 million figure refers to the season reperforming loans we've been buying. As I said during the opening remarks, that amount has decreased as a result of the securitization we finished on July 10; so it was a $630 million number and has since fallen to, I believe, just over $300 million of UPB and I think $283 million of borrowing, which sits on a 1-year non-mark-to-market facility established in July.
Eric Hagen
analystUnderstood, that's quite useful. Now, regarding the assets you securitized during the prior quarter — those three transactions you completed — what loss adjusted yield applied to the tranches you kept from them?
Mohit Marria
executiveIn our base case projections, that loss adjusted yield falls somewhere in the range of 8% to 9%.
Eric Hagen
analyst8% to 9%. Understood.
Trevor Cranston
analystI have another question regarding the financing side. Regarding the 46% of non-agency financing that remains mark-to-market, could you elaborate on your thinking there, whether you plan to gradually shift more of it into non-mark-to-market facilities, or how we should view that going forward?
Mohit Marria
executiveHi, Trevor. Most of that 46% consists of middle mezz securities from securitizations we have completed. As I mentioned in my opening remarks, we have 13 deals callable within the next 12 months. If we intend to call them, we don't want to place them on longer tenures and potentially incur a breakup fee. So I believe we will keep the financing short. Those are money good assets, and the counterparties providing the financing are also comfortable with longer tenures and will work with us should we call those. That accounts for the bulk of the 46%. The remaining assets are legacy assets that, if we needed to raise liquidity by selling non-agency assets, give us that ability. So we intentionally want to keep those short. By short, I mean financing of 3 to 6 months still.
Trevor Cranston
analystAll right, understood. Then, Rob, it's possible you just addressed this, yet could you make clear what drove the change in book value during this quarter? Given that credit spreads, generally, appeared to narrow by a fair amount across many asset classes?
Rob Colligan
executiveOf course, Trevor. Like I said, the liability portion of our balance sheet, where we do more, rose at a faster rate or on a higher basis than the asset portion. However, the other factor is the convertible issuance we brought to market in April, which had a sizable effect this quarter. Clearly, it was great for liquidity, and holding that much cash on our balance sheet amid distress mattered a lot to us; yet from a book value standpoint, the convert by itself cut book value by roughly $1.22 per share. And we also have a capped call in place that lowered this by another approximately $0.15. We haven't triggered the capped call or exercised our options on it, so there could be some book value recovery there; but the convert certainly had a significant impact on book value this quarter.
Matt Lambiase
executiveAlright, thanks for joining us on this call covering Chimera Investment Corp's results for the second quarter of 2020. I'm looking forward to talking with all of you again in November. Thanks.
Operator
operatorThat wraps up today's conference call. We appreciate everyone taking part, and we ask that you please hang up your lines.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Chimera Investment Corporation transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.
Get the API View API docs →For developers and AI pipelines
Programmatic access to Chimera Investment Corporation earnings transcripts and 132,000+ others is available through the
EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments,
full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.
More tools for stock research
OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Chimera Investment Corporation or any ticker on your watchlist.
StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.